{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:22:58Z","timestamp":1761110578429},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.medcli.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T14:03:50Z","timestamp":1614175430000},"page":"20-21","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u00bfDosis m\u00e1ximas de bloqueantes del eje renina-angiotensina en nefropat\u00eda diab\u00e9tica?"],"prefix":"10.1016","volume":"157","author":[{"given":"Nicol\u00e1s Roberto","family":"Robles P\u00e9rez-Monteoliva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Ar\u00e9valo Lorido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2021.01.007_bib0090","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/jcm4091761","article-title":"Non-proteinuric diabetic nephropathy","volume":"4","author":"Robles","year":"2015","journal-title":"J Clin Med."},{"key":"10.1016\/j.medcli.2021.01.007_bib0095","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc07-0140","article-title":"Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group","volume":"30","author":"Rigalleau","year":"2007","journal-title":"Diabetes Care."},{"issue":"4S","key":"10.1016\/j.medcli.2021.01.007_bib0100","first-page":"S1","article-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"98","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.medcli.2021.01.007_bib0105","first-page":"535","volume":"139","author":"Robles","year":"2012","journal-title":"\u00bfEs peligroso reducir excesivamente la presi\u00f3n arterial?.: la curva Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2021.01.007_bib0110","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"List of authors\/Task Force members: 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens."},{"key":"10.1016\/j.medcli.2021.01.007_bib0115","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jch.13024","article-title":"Does a blood pressure J curve exist for patients with chronic kidney disease?","volume":"19","author":"Robles","year":"2017","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.medcli.2021.01.007_bib0120","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/jch.13396","article-title":"Antihypertensive treatment and renal protection: Is there a J-curve relationship?","volume":"20","author":"Viazzi","year":"2018","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.medcli.2021.01.007_bib0125","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/dom.12978","article-title":"Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study","volume":"19","author":"Connelly","year":"2017","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.medcli.2021.01.007_bib0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"EMPA-REG OUTCOME Investigators. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2021.01.007_bib0135","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.medcli.2021.01.007_bib0140","article-title":"The healthy aging, and diseased kidney: relationship with cardiovascular disease","author":"Morcos","year":"2020","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.medcli.2021.01.007_bib0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","article-title":"Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.medcli.2021.01.007_bib0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996-2016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2021.01.007_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/lds030","article-title":"Renal complications of diabetes","volume":"104","author":"Min","year":"2012","journal-title":"Br Med Bull."},{"key":"10.1016\/j.medcli.2021.01.007_bib0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.ki.5000068","article-title":"Use of ultrahigh RAAS blockade: Implications for exacerbation of renal failure","volume":"69","author":"Onuigbo","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.medcli.2021.01.007_bib0165","unstructured":"Clair JS. A New Model of Tracheostomy Care: Closing the Research\u2013Practice Gap. En: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in Patient Safety: From Research to Implementation (Volume 3: Implementation Issues). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. Table 1, AHRQ scale of research grades and levels. Disponible en: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK20542\/table\/A5857\/."},{"key":"10.1016\/j.medcli.2021.01.007_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248413501018","article-title":"Renin-angiotensin system blocking drugs","volume":"19","author":"Robles","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T10:06:51Z","timestamp":1706004411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775321000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0025775321000373"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2021.01.007","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00bfDosis m\u00e1ximas de bloqueantes del eje renina-angiotensina en nefropat\u00eda diab\u00e9tica?","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}